Tong Ren Tang Technologies Co. Ltd. Stock Deutsche Boerse AG
Equities
TNG
CNE100000585
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.645 EUR | -2.27% | -3.73% | -15.69% |
Sales 2024 * | 7.5B 1.04B 954M | Sales 2025 * | 8.25B 1.14B 1.05B | Capitalization | 6.53B 902M 831M |
---|---|---|---|---|---|
Net income 2024 * | 631M 87.13M 80.32M | Net income 2025 * | 674M 93.07M 85.8M | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | 499M 68.96M 63.57M | Net cash position 2025 * | 2.32B 321M 296M | EV / Sales 2025 * | 0.51 x |
P/E ratio 2024 * |
10.3
x | P/E ratio 2025 * |
9.62
x | Employees | 4,101 |
Yield 2024 * |
3.33% | Yield 2025 * |
3.92% | Free-Float | 45.64% |
1 day | -2.27% | ||
1 week | -3.73% | ||
1 month | +12.17% | ||
6 months | -16.23% | ||
Current year | -15.69% |
Managers | Title | Age | Since |
---|---|---|---|
Jia Fu Chen
CEO | Chief Executive Officer | 55 | 23-06-14 |
Guan Zhao Han
LAW | General Counsel | 45 | - |
Shu Wu Zhao
PRN | Corporate Officer/Principal | 42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leung Huel Ting
BRD | Director/Board Member | 71 | 00-10-10 |
Ching Har Chan
BRD | Director/Board Member | 67 | 18-06-11 |
Yuan Jing Zhan
BRD | Director/Board Member | 80 | 18-06-11 |
Date | Price | Change |
---|---|---|
24-05-24 | 0.645 | -2.27% |
24-05-23 | 0.66 | -2.94% |
24-05-22 | 0.68 | +12.40% |
24-05-21 | 0.605 | -9.70% |
24-05-20 | 0.67 | 0.00% |
Delayed Quote Deutsche Boerse AG, May 24, 2024 at 03:49 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.65% | 6.04B | |
-19.68% | 4.27B | |
+4.49% | 3.28B | |
-15.69% | 2.96B | |
-5.64% | 2.43B | |
+44.89% | 1.93B | |
-12.71% | 1.59B | |
-4.27% | 1.58B | |
-14.86% | 1.5B |
- Stock Market
- Equities
- 1666 Stock
- TNG Stock